Market Research Logo

BioTime Inc (BTX) - Financial and Strategic SWOT Analysis Review

BioTime Inc (BTX) - Financial and Strategic SWOT Analysis Review provides

- you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

BioTime Inc (BioTime) is a biotechnology company which focuses on regenerative medicine and plasma volume expanders. The company’s Hextend is a blood plasma volume expander used for the treatment of hypovolemia in surgery, emergency trauma treatment, and other applications. It is also developing Renevia facial aesthetics product, a potential treatment for facial lipoatrophy; AST-VAC1 and AST-VAC2 autologous (patient-specific) cancer vaccines; Premvia for tendon and wound-management applications; OpRegen for the treatment of dry form of age-related macular degeneration (AMD); AST-OPC1 for spinal cord injury rehabilitation; HyStem hydrogel products; and mobile health software products. BioTime’s products can be used in oncology, neuroscience, orthopedics and blood and vascular diseases. Its products are developed on its pluripotent stem technology. The company has operations in the US, Hong Kong, Israel and Singapore. BioTime is headquartered in California, the US.

BioTime Inc Key Recent Developments

Aug 02,2018: BioTime reports second quarter results and recent corporate accomplishments-2018
Aug 02,2018: BioTime reports second quarter results and recent corporate accomplishments for 2018
Jun 29,2018: BioTime Awarded Grant from the National Institutes of Health
Jun 29,2018: BioTime Awarded Grant From the NIH (National Institutes of Health)
Jun 05,2018: AgeX Therapeutics Appoints John F. Mauldin to Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
BioTime Inc - Key Facts
BioTime Inc - Key Employees
BioTime Inc - Key Employee Biographies
BioTime Inc - Major Products and Services
BioTime Inc - History
BioTime Inc - Company Statement
BioTime Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
BioTime Inc - Business Description
BioTime Inc - SWOT Analysis
SWOT Analysis - Overview
BioTime Inc - Strengths
BioTime Inc - Weaknesses
BioTime Inc - Opportunities
BioTime Inc - Threats
BioTime Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
BioTime Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
BioTime Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
BioTime Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 14, 2018: Oncocyte reports second quarter 2018 financial results and positive corporate developments
Aug 02, 2018: BioTime reports second quarter results and recent corporate accomplishments-2018
Jun 05, 2018: AgeX Therapeutics Appoints John F. Mauldin to Board of Directors
May 15, 2018: OncoCyte Reports First Quarter 2018 Financial Results
May 10, 2018: BioTime Reports First Quarter Results and Recent Corporate Accomplishments
Apr 03, 2018: Leading Molecular Diagnostics Executive Ronnie Andrews Appointed to OncoCyte’s Board of Directors
Apr 02, 2018: OncoCyte Names Cavan Redmond Chairman of the Board of Directors
Apr 02, 2018: OncoCyte Files Patents for 190 Newly Identified Novel Lung Cancer Biomarkers
Apr 02, 2018: Oncocyte Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 15, 2018: BioTime Reports Fourth Quarter and Fiscal 2017 Results
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
BioTime Inc, Key Facts
BioTime Inc, Key Employees
BioTime Inc, Key Employee Biographies
BioTime Inc, Major Products and Services
BioTime Inc, History
BioTime Inc, Subsidiaries
BioTime Inc, Joint Venture
BioTime Inc, Key Competitors
BioTime Inc, Ratios based on current share price
BioTime Inc, Annual Ratios
BioTime Inc, Annual Ratios (Cont...1)
BioTime Inc, Annual Ratios (Cont...2)
BioTime Inc, Interim Ratios
BioTime Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
BioTime Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
BioTime Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
BioTime Inc, Performance Chart (2013 - 2017)
BioTime Inc, Ratio Charts
BioTime Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
BioTime Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report